Tech Company Financing Transactions

ReCode Therapeutics Funding Round

ReCode Therapeutics, based in Menlo Park, secured $50 million in investment from Bioluminescence Ventures, Solasta Ventures and Amgen Ventures.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B

Bioluminescence Ventures (Lead Investor) (Kouki Harasaki)

Solasta Ventures (Lead Investor)

Amgen Ventures

EcoR1 Capital Management (Oleg Nodelman)

Leaps by Bayer (Juergen Eckhardt)

Matrix Capital Management

MPM Capital (Ed Hurwitz)

OrbiMed (Peter Thompson)

Osage University Partners

Pfizer Venture Investments (Rana Al-Hallaq)

Sanofi Ventures

Vida Ventures (Helen Kim)

Proceeds Purpose
The company intends to use the funds to advance its primary ciliary dyskinesia and cystic fibrosis clinical development programs and to expand its proprietary Selective Organ Targeting (SORT) lipid nanoparticle (LNP) pipeline to include mRNA and gene correction therapeutics for central nervous system, lung, liver and musculoskeletal indications.

Company Information

Company Status
Private & Independent
Mailing Address
1455 Adams Dr.
Menlo Park, CA 94025
Email Address
ReCode Therapeutics is a biopharmaceutical company developing precision medicines for pulmonary diseases with significant unmet medical need. ReCode's diverse pipeline includes lead programs for primary ciliary dyskinesia (PCD) and nonsense mutations in cystic fibrosis (CF).
ReCode Therapeutics LinkedIn Company Profile
Social Media
ReCode Therapeutics Company Twitter Account
Company News
ReCode Therapeutics News
ReCode Therapeutics on Facebook
ReCode Therapeutics on YouTube

Management Team

Email & Social
Chief Executive Officer
David Lockhart
  David Lockhart LinkedIn Profile  David Lockhart Twitter Account  David Lockhart News  David Lockhart on Facebook



Browse more venture capital transactions:

Prev: 9/19/2023: ARX venture capital transaction
Next: 9/19/2023: Hibob venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary